Samuel Whiting - Net Worth and Insider Trading

Samuel Whiting Net Worth

The estimated net worth of Samuel Whiting is at least $5,646 dollars as of 2024-06-18. Samuel Whiting is the Chief Medical Officer of Tempest Therapeutics Inc and owns about 1,901 shares of Tempest Therapeutics Inc (TPST) stock worth over $5,646. Details can be seen in Samuel Whiting's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Samuel Whiting has not made any transactions after 2022-01-06 and currently still holds the listed stock(s).

Transaction Summary of Samuel Whiting

To

Samuel Whiting Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel Whiting owns 1 companies in total, including Tempest Therapeutics Inc (TPST) .

Click here to see the complete history of Samuel Whiting’s form 4 insider trades.

Insider Ownership Summary of Samuel Whiting

Ticker Comapny Transaction Date Type of Owner
TPST Tempest Therapeutics Inc 2022-01-06 Chief Medical Officer

Samuel Whiting Latest Holdings Summary

Samuel Whiting currently owns a total of 1 stock. Samuel Whiting owns 1,901 shares of Tempest Therapeutics Inc (TPST) as of January 6, 2022, with a value of $5,646.

Latest Holdings of Samuel Whiting

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TPST Tempest Therapeutics Inc 2022-01-06 1,901 2.97 5,646

Holding Weightings of Samuel Whiting


Samuel Whiting Form 4 Trading Tracker

According to the SEC Form 4 filings, Samuel Whiting has made a total of 1 transactions in Tempest Therapeutics Inc (TPST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tempest Therapeutics Inc is the acquisition of 1,700 shares on January 6, 2022, which cost Samuel Whiting around $8,160.

Insider Trading History of Samuel Whiting

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samuel Whiting Trading Performance

GuruFocus tracks the stock performance after each of Samuel Whiting's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuel Whiting is -11.51%. GuruFocus also compares Samuel Whiting's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuel Whiting within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samuel Whiting's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samuel Whiting

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -23.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -19.4 LIMIT LIMIT LIMIT LIMIT LIMIT

Samuel Whiting Ownership Network

Ownership Network List of Samuel Whiting

No Data

Ownership Network Relation of Samuel Whiting

Insider Network Chart

Samuel Whiting Owned Company Details

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Samuel Whiting is the Chief Medical Officer of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include Corporate Controller Justin Trojanowski , VP of Strategy and Finance Nicholas Maestas , and 10 percent owner Versant Side Fund Iv, L.p. .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tempest Therapeutics Inc Insider Transactions

No Available Data

Samuel Whiting Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel Whiting. You might contact Samuel Whiting via mailing address: C/o Tempest Therapeutics, Inc., 7000 Shoreline Court, Suite 275, South San Francisco Ca 94080.

Discussions on Samuel Whiting

No discussions yet.